4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-22-015773
Chief Executive Officer bought 12,000 shares at an average $1.96 ($23,560)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2022-05-31 | Purchase | +8,000 | $2.03 | $16,240 | 23,500 | D |
| Huntsman Ronald Kirk Chief Executive Officer | 2022-06-01 | Purchase | +4,000 | $1.83 | $7,320 | 27,500 | D |
| Open-market purchases · 12,000 sh · avg $1.96 · $23,560 | |||||||
Loading xslF345X03/ownership.xml…